A Multicenter, non-comparative trial on the contraceptive efficacy, safety, and tolerability of LPRI-424 (dienogest 2 mg/ethinyl estradiol 0.02 mg) during 13 cycles
New Birth Control Pill Study
Sponsor: Chemo Research S.L
Enrolling: Female Patients Only
Study Length: 13 Months
Clinic Visits: 9
IRB Number: AAAS7395
U.S. Govt. ID: NCT03945513
Contact: Carolyn Westhoff: 212-305-9368 / clw3@cumc.columbia.edu
Additional Study Information: If you are a woman between the ages of 18 and 35, are pre-menopausal, sexually active and do NOT wish to become pregnant, you are invited to see if you may qualify for a research study. The purpose of this research study is to test the effectiveness of an investigational oral birth control pill. If you qualify, you will receive investigational study medication, study-related medical exams, and laboratory services at no charge. You may also be reimbursed for time, travel, and other expenses.
This study is closed
Investigator
Carolyn Westhoff, MD
Do You Qualify?
Are you between 18 and 35 years of age? Yes No
Are you currently sexually active with a male partner? Yes No
Do you have a regular menstrual cycle? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Carolyn Westhoff
clw3@cumc.columbia.edu
212-305-9368
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE